文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

整合转录组与加权基因共表达网络分析识别UCHL1-MUCL1轴为脓毒症内皮功能障碍的关键调控因子

Integrated Transcriptomic and Weighted Gene Coexpression Network Analyses Identify the UCHL1-MUCL1 Axis as a Key Regulator of Endothelial Dysfunction in Sepsis.
PubMed 文献 · Shock · 2026-02-14
一句话结论脓毒症中UCHL1通过去泛素化稳定MUCL1,经β-catenin/NF-κB通路促进内皮炎症与凋亡,靶向该轴可能减轻血管内皮功能障碍。

该研究整合GSE46955数据集差异表达基因与加权基因共表达网络分析,识别出70个上调基因,其中MUCL1与脓毒症显著相关。在脂多糖处理的人脐静脉内皮细胞中,MUCL1敲低减轻炎症(降低肿瘤坏死因子-α、白细胞介素6、白细胞介素8和ICAM-1)和凋亡;UCHL1通过去泛素化稳定MUCL1蛋白,UCHL1沉默改善脂多糖诱导的效应,而MUCL1过表达逆转这些保护作用。UCHL1沉默减弱β-catenin/NF-κB通路激活,该效应与MUCL1表达调控相关。作者认为靶向MUCL1或其调控因子UCHL1可能代表减轻脓毒症血管内皮功能障碍的有前景的治疗策略。

要点

  • 在脂多糖处理的人脐静脉内皮细胞中,MUCL1敲低减轻炎症(降低肿瘤坏死因子-α、白细胞介素6、白细胞介素8和ICAM-1)和凋亡。
  • UCHL1通过去泛素化稳定MUCL1蛋白;UCHL1沉默改善脂多糖诱导的效应,而MUCL1过表达逆转这些保护作用。
  • UCHL1沉默减弱β-catenin/NF-κB通路激活,该效应与MUCL1表达调控相关。
  • 作者认为靶向MUCL1或其调控因子UCHL1可能代表减轻脓毒症血管内皮功能障碍的有前景的治疗策略。

适用人群与场景

  • 脓毒症相关血管内皮功能障碍的体外研究:脂多糖处理的人脐静脉内皮细胞(HUVECs)。

研究设计与关键结果

  • 研究类型:整合差异表达基因分析与加权基因共表达网络分析的转录组学研究,并在脂多糖处理的人脐静脉内皮细胞中进行实验验证。
  • 从GSE46955数据集识别出70个上调基因,MUCL1为与脓毒症显著相关的顶级上调基因之一。
  • 脂多糖处理显著增加人脐静脉内皮细胞中MUCL1表达;MUCL1敲低减轻脂多糖诱导的炎症(降低肿瘤坏死因子-α、白细胞介素6、白细胞介素8和ICAM-1)和凋亡。
  • UCHL1通过去泛素化稳定MUCL1蛋白;UCHL1沉默改善脂多糖诱导的效应,而MUCL1过表达逆转这些保护作用。
  • UCHL1沉默减弱β-catenin/NF-κB通路激活,该效应与MUCL1表达调控相关。

证据类型、等级与局限

  • 证据类型:转录组学分析结合体外细胞实验(人脐静脉内皮细胞)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为靶向MUCL1或其调控因子UCHL1可能代表减轻脓毒症血管内皮功能障碍的有前景的治疗策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, with vascular endothelial cell dysfunction playing a critical role in its pathogenesis. Endothelial injury contributes to microcirculatory failure, systemic inflammation, and multiorgan dysfunction, leading to high mortality in sepsis patients. However, the molecular mechanisms underlying vascular endothelial cell dysfunction in sepsis remain poorly understood. The study analyzed the underlying mechanism by integrating differentially expressed genes and weighted gene coexpression network analysis.

METHODS: To identify key drivers of the hyperinflammatory response in sepsis, differentially expressed genes were analyzed from the GSE46955 dataset. Weighted gene coexpression network analysis was performed to identify sepsis-associated modules. Hub genes were validated in lipopolysaccharide (LPS)-treated human umbilical vein endothelial cells (HUVECs) via quantitative real-time PCR and Western blotting. Functional assays, including enzyme-linked immunosorbent assay and flow cytometry, were conducted to investigate the role of mucin-like 1 (MUCL1) and its regulator, ubiquitin C-terminal hydrolase L1 (UCHL1), in LPS-induced endothelial injury. Coimmunoprecipitation, ubiquitination, and cycloheximide assays were performed to validate the association of MUCI and UCHL1 in HUVECs.

RESULTS: A total of 70 upregulated genes were identified, with MUCL1 emerging as a top upregulated gene significantly correlated with sepsis. LPS treatment markedly increased MUCL1 expression in HUVECs. MUCL1 knockdown attenuated LPS-induced inflammation (reduced tumor necrosis factor-alpha, interleukin 6 [IL-6], IL-8, and ICAM-1) and apoptosis. Further analysis revealed that UCHL1 stabilized MUCL1 protein by deubiquitination. UCHL1 silencing ameliorated LPS-induced effects in HUVECs; however, MUCL1 overexpression reversed these protective effects. UCHL1 silencing attenuated the activation of the β-catenin/NF-κB pathway, an effect that was associated with the regulation of MUCL1 expression.

CONCLUSIONS: The UCHL1-MUCL1 axis promoted sepsis-induced endothelial inflammation and apoptosis through the regulation of the β-catenin/nuclear factor κB pathway. Targeting MUCL1 or its regulator UCHL1 may represent a promising therapeutic strategy to mitigate vascular endothelial dysfunction in sepsis.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Yan S, Zhang Y, He Y, et al. Integrated Transcriptomic and Weighted Gene Coexpression Network Analyses Identify the UCHL1-MUCL1 Axis as a Key Regulator of Endothelial Dysfunction in Sepsis. Shock. 2026. PMID: 41770679. doi:10.1097/SHK.0000000000002810

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。